PARK HA BIOLOGICAL TECH-A

BYAHNASDAQ

🏆 #4335 by market capUS Equity

$3.54▲ $0.09 (+2.61%)

Market closed · at close

1h—

24h▲ 2.6%

7d▲ 32.8%

14d▲ 29.5%

30d▼ 3.8%

1y▼ 98.6%

🏦Market Cap

$22M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

94.3%

High

💵FCF Margin

43.1%

Strong

⚖️P/S Ratio

21.6x

Expensive

Otter Score

Weak

Trading Snapshot

Day Range: $3.53 – $3.57
52-Week Range: —
Volume: $1.51B
Avg Volume: $1.81B
Shares Outstanding: 6.3M
Next Earnings: Oct 9, 2026

Fundamentals Snapshot

Annual Revenue: $3M
Last Q Revenue: $1M
P/E Ratio: —
P/S Ratio: 21.6x
EPS (TTM): —
Dividend Yield: —

Why Investors Own BYAH

✓High-growth profile — revenue up -3.3% YoY with expanding US Equity exposure.
✓Healthy economics — 38% gross margin and 13% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$3M▼ −1.5% YoY

Gross Margin (TTM)

37.5%▲ +3.4% YoY

Operating Income (TTM)

$214,612▼ −1.5% YoY

Free Cash Flow (TTM)

$323,180▼ −1.5% YoY

About PARK HA BIOLOGICAL TECH-A

This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China. The company executes these activities through its affiliated subsidiaries, which manage both direct product sales and the provision of franchise services.

🦦